Gemini Therapeutics Analysis
| GMTXDelisted Stock | USD 17.95 0.05 0.28% |
Gemini Therapeutics is overvalued with Real Value of 14.81 and Hype Value of 17.95. The main objective of Gemini Therapeutics delisted stock analysis is to determine its intrinsic value, which is an estimate of what Gemini Therapeutics is worth, separate from its market price. There are two main types of Gemini Therapeutics' stock analysis: fundamental analysis and technical analysis. Fundamental analysis focuses on the financial and economic factors that affect Gemini Therapeutics' performance, such as revenue growth, earnings, and financial stability. Technical analysis, on the other hand, focuses on the price and volume data of Gemini Therapeutics' stock to identify patterns and trends that may indicate its future price movements.
The Gemini Therapeutics stock is traded in the USA on NASDAQ Exchange, with the market opening at 09:30:00 and closing at 16:00:00 every Mon,Tue,Wed,Thu,Fri except for officially observed holidays in the USA. Gemini Therapeutics is usually not traded on Thanksgiving Day, Christmas Day, New Year 's Day, Dr . Martin Luther King Jr 's Birthday, Washington 's Birthday, Good Friday, Memorial Day, Juneteenth Holiday, Independence Day, Labour Day. Gemini Stock trading window is adjusted to America/New York timezone. Here, you can get updates on important government artifacts, including earning estimates, SEC corporate filings, announcements, and Gemini Therapeutics' ongoing operational relationships across important fundamental and technical indicators.
Gemini |
Gemini Stock Analysis Notes
About 88.0% of the company shares are owned by institutional investors. The company has price-to-book (P/B) ratio of 0.68. Some equities with similar Price to Book (P/B) outperform the market in the long run. Gemini Therapeutics recorded a loss per share of 1.58. The entity had not issued any dividends in recent years. The firm had 1:10 split on the 30th of December 2022. Gemini Therapeutics, Inc., a clinical stage precision medicine company, engages in developing various therapeutic compounds for treating genetically defined age-related macular degeneration . Gemini Therapeutics, Inc. was founded in 2015 and is headquartered in Cambridge, Massachusetts. Gemini Therapeutics operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 24 people. To learn more about Gemini Therapeutics call the company at 617 401 4400 or check out https://www.geminitherapeutics.com.Gemini Therapeutics Investment Alerts
Many investors view ongoing market volatility as an opportunity to purchase more delisted stocks at a favorable price or short it to generate a bearish trend profit opportunity. If you are one of those investors, make sure you clearly understand the position you are entering. Gemini Therapeutics' investment alerts are automatically generated signals that are significant enough to either complement your investing judgment regarding Gemini Therapeutics or challenge it. These alerts can help you understand what you are buying and avoid costly mistakes.
| Gemini Therapeutics is not yet fully synchronised with the market data | |
| Gemini Therapeutics has a very high chance of going through financial distress in the upcoming years | |
| Net Loss for the year was (71.87 M) with profit before overhead, payroll, taxes, and interest of 0. | |
| Gemini Therapeutics currently holds about 108.66 M in cash with (59.7 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 2.51. | |
| Over 88.0% of the company shares are owned by institutional investors |
Gemini Market Capitalization
The company currently falls under 'Micro-Cap' category with a current market capitalization of 58.49 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Gemini Therapeutics's market, we take the total number of its shares issued and multiply it by Gemini Therapeutics's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities.Gemini Therapeutics Predictive Daily Indicators
Gemini Therapeutics intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of Gemini Therapeutics stock daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.
About Gemini Stock Analysis
Stock analysis is the technique used by a trader or investor to examine and evaluate how Gemini Therapeutics prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Gemini shares will generate the highest return on investment. We also built our delisted stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Delisted Stock such as Gemini Therapeutics. By using and applying Gemini Stock analysis, traders can create a robust methodology for identifying Gemini entry and exit points for their positions.
Gemini Therapeutics, Inc., a clinical stage precision medicine company, engages in developing various therapeutic compounds for treating genetically defined age-related macular degeneration . Gemini Therapeutics, Inc. was founded in 2015 and is headquartered in Cambridge, Massachusetts. Gemini Therapeutics operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 24 people.
Be your own money manager
As an investor, your ultimate goal is to build wealth. Optimizing your investment portfolio is an essential element in this goal. Using our stock analysis tools, you can find out how much better you can do when adding Gemini Therapeutics to your portfolios without increasing risk or reducing expected return.Did you try this?
Run Earnings Calls Now
Earnings CallsCheck upcoming earnings announcements updated hourly across public exchanges |
| All Next | Launch Module |
Check out Risk vs Return Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in estimate. You can also try the Equity Search module to search for actively traded equities including funds and ETFs from over 30 global markets.
Other Consideration for investing in Gemini Stock
If you are still planning to invest in Gemini Therapeutics check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Gemini Therapeutics' history and understand the potential risks before investing.
| Economic Indicators Top statistical indicators that provide insights into how an economy is performing | |
| Money Managers Screen money managers from public funds and ETFs managed around the world | |
| My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like | |
| Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes | |
| ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments | |
| Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
| Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity |